↓ Skip to main content

Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death

Overview of attention for article published in BMC Cancer, September 2011
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
40 Dimensions

Readers on

mendeley
27 Mendeley
Title
Brain metastases from breast cancer: prognostic significance of HER-2 overexpression, effect of trastuzumab and cause of death
Published in
BMC Cancer, September 2011
DOI 10.1186/1471-2407-11-395
Pubmed ID
Authors

Romuald Le Scodan, Ludivine Jouanneau, Christophe Massard, Maya Gutierrez, Youlia Kirova, Pascal Cherel, Julie Gachet, Alain Labib, Emmanuelle Mouret-Fourme

Abstract

To access the prognostic significance of HER-2 overexpression, the effect of trastuzumab and the cause of death in patients with brain metastases (BM) from breast cancer (BC).

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Belgium 1 4%
Unknown 26 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 7 26%
Other 6 22%
Professor > Associate Professor 3 11%
Student > Postgraduate 2 7%
Student > Bachelor 2 7%
Other 5 19%
Unknown 2 7%
Readers by discipline Count As %
Medicine and Dentistry 10 37%
Agricultural and Biological Sciences 5 19%
Arts and Humanities 2 7%
Immunology and Microbiology 1 4%
Unspecified 1 4%
Other 4 15%
Unknown 4 15%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 September 2011.
All research outputs
#1,957,000
of 4,504,824 outputs
Outputs from BMC Cancer
#748
of 2,430 outputs
Outputs of similar age
#20,621
of 64,442 outputs
Outputs of similar age from BMC Cancer
#21
of 96 outputs
Altmetric has tracked 4,504,824 research outputs across all sources so far. This one has received more attention than most of these and is in the 55th percentile.
So far Altmetric has tracked 2,430 research outputs from this source. They receive a mean Attention Score of 2.4. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 64,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.